Revenue and Profit Performance - Revenue for Q1 2024 was RMB 19.57 billion, a decrease of 41.13% year-over-year[3] - Operating revenue for Q1 2024 was 19.57 billion CNY, a decrease from 33.24 billion CNY in Q1 2023[16] - Net profit for Q1 2024 was -647.10 million CNY, compared to 10.94 billion CNY in Q1 2023[16] - Net profit attributable to shareholders was a loss of RMB 786.74 million, down 109.15% year-over-year[3] - Net profit attributable to parent company shareholders was -786.74 million yuan, compared to 8.60 billion yuan in the same period last year[17] - Comprehensive income totaled -638.91 million yuan, compared to 10.93 billion yuan in the same period last year[17] - Basic earnings per share were -0.1748 yuan, compared to 1.9108 yuan in the same period last year[17] Cash Flow and Financial Position - Operating cash flow was negative RMB 1.39 billion, a decrease of 162.08% year-over-year[3] - Net cash flow from operating activities was -1.39 billion yuan, compared to 2.25 billion yuan in the same period last year[19] - Cash received from sales of goods and services was 20.37 billion yuan, down from 32.48 billion yuan in the same period last year[18] - Cash received from investments was 7.50 billion yuan, up from 3.10 billion yuan in the same period last year[19] - Net cash flow from investing activities was -10.03 billion yuan, compared to -17.51 billion yuan in the same period last year[19] - Cash received from financing activities was 18.22 billion yuan, up from 6.75 billion yuan in the same period last year[19] - Net cash flow from financing activities was 15.73 billion yuan, compared to 6.06 billion yuan in the same period last year[20] - Net increase in cash and cash equivalents was 4.31 billion yuan, compared to -9.20 billion yuan in the same period last year[20] - The company's monetary funds increased to RMB 28.29 billion as of March 31, 2024, compared to RMB 19.42 billion at the end of 2023[12] Assets and Liabilities - Total assets increased by 9.35% to RMB 164.36 billion compared to the end of the previous year[3] - Total assets increased to 179.72 billion CNY from 164.36 billion CNY in the previous quarter[13][14] - Total liabilities increased to 106.53 billion CNY from 90.53 billion CNY in the previous quarter[14] - Fixed assets stood at 66.96 billion CNY, slightly down from 68.27 billion CNY in the previous quarter[13] - Long-term loans increased to 41.62 billion CNY from 28.76 billion CNY in the previous quarter[14] - Total equity attributable to owners of the parent company was 60.77 billion CNY, down from 61.53 billion CNY in the previous quarter[14] - The company's total current assets reached RMB 70.96 billion as of March 31, 2024, up from RMB 63.24 billion at the end of 2023[12] - Trade receivables decreased to RMB 5.16 billion as of March 31, 2024, from RMB 6.99 billion at the end of 2023[12] - Inventory increased significantly to RMB 11.27 billion as of March 31, 2024, compared to RMB 7.79 billion at the end of 2023[12] Expenses and Investments - Sales expenses rose by 67.16% due to expanded component sales[6] - Sales expenses increased to 464.44 million CNY from 277.85 million CNY in Q1 2023[16] - Financial expenses increased by 96.21% due to expanded borrowing[6] - Financial expenses rose to 277.02 million CNY from 141.19 million CNY in Q1 2023[16] - Research and development expenses were 263.77 million CNY, down from 285.53 million CNY in Q1 2023[16] - Long-term investments surged by 443.88% due to investment in Shiji Biotechnology[6] - Inventory increased by 44.72% due to business expansion[6] Shareholder and Share Repurchase Information - The company's total number of ordinary shareholders at the end of the reporting period was 353,475[8] - The controlling shareholder, Tongwei Group, plans to increase its shareholding by RMB 1-2 billion between February 1, 2024, and January 31, 2025[11] - As of the report date, Tongwei Group has already increased its shareholding by 1,692,014 A shares, with a total investment of approximately RMB 402.14 million[11] - The company plans to repurchase RMB 2-4 billion worth of A shares between April 29, 2024, and April 28, 2025, at a price not exceeding RMB 36 per share[11] - The repurchased shares are intended for employee stock ownership plans or equity incentives, and if not used, will be canceled[11] - The China Industrial and Commercial Bank-Huatai-PineBridge CSI 300 ETF held 29.14 million shares, representing 0.65% of the total shares[10] - The China Bank-Huatai-PineBridge CSI Photovoltaic Industry ETF held 27.30 million shares, representing 0.61% of the total shares[10] Other Income and Government Subsidies - Other income increased by 225.76% due to higher government subsidies[8]
通威股份(600438) - 2024 Q1 - 季度财报